menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Joel M. Gelfand, MD, MSCE
Joel M. Gelfand, MD, MSCE
  • Professor of Dermatology and Epidemiology
  • Univ. of Pennsylvania Perelman School of Medicine
  • Director
  • Psoriasis and Phototherapy Treatment Center
Joel M. Gelfand MD MSCE is Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania's Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 200 scientific publications, editorials, reviews, and text book chapters (cited over 16,600 times, H index 57) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association's Psoriasis Achievement Award, PENN's Marjorie Bowman Award, Penn's Department of Biostatistics and Epidemiology's epidemiology teaching award, NPF's inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology's Eugene M. Farber lecture and the American Academy of Dermatology's Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.
LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 4/6/20